Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis.

Kobold N, Jenko B, Tomšič M, Dolžan V, Praprotnik S.

Isr Med Assoc J. 2019 May;5(21):333-338.

2.

Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?

Praprotnik S, Hočevar A, Rotar Ž, Tomšič M, Gašperšič N, Perdan Pirkmajer K.

Rheumatology (Oxford). 2019 Jul 1;58(7):1310-1312. doi: 10.1093/rheumatology/kez082. No abstract available.

PMID:
30859223
3.

The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.

Lakota K, Perdan-Pirkmajer K, Sodin-Šemrl S, Čučnik S, Šubelj V, Prosenc K, Mrak Poljšak K, Tomšič M, Ambrožič A, Praprotnik S.

Clin Rheumatol. 2019 May;38(5):1277-1292. doi: 10.1007/s10067-019-04439-y. Epub 2019 Feb 14.

PMID:
30761436
4.

Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels.

Ogrič M, Žigon P, Drobne D, Štabuc B, Sodin-Semrl S, Čučnik S, Praprotnik S.

Immunol Res. 2018 Dec;66(6):726-736. doi: 10.1007/s12026-018-9050-3.

PMID:
30569379
6.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnström M, Praprotnik S, Sène D, Bartoloni E, Solans R, Rischmueller M, Suzuki Y, Isenberg DA, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura T, Giacomelli R, Devauchelle-Pensec V, Knopf A, Bombardieri M, Trevisani VF, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenveider C, Horvath IF, Sivils KL, Olsson P, De Vita S, Sánchez-Guerrero J, Kilic L, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):102-112. Epub 2018 Aug 14.

7.

Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients.

Burja B, Feichtinger J, Lakota K, Thallinger GG, Sodin-Semrl S, Kuret T, Rotar Ž, Ješe R, Žigon P, Čučnik S, Mali P, Praprotnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):317-329. doi: 10.1007/s10067-018-4240-x. Epub 2018 Aug 24.

PMID:
30143961
8.

Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.

Žigon P, Podovšovnik A, Ambrožič A, Tomšič M, Hočevar A, Gašperšič N, Rotar Ž, Praprotnik S, Šemrl SS, Čučnik S.

Clin Rheumatol. 2019 Feb;38(2):371-378. doi: 10.1007/s10067-018-4251-7. Epub 2018 Aug 11.

PMID:
30099654
9.

Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA.

Ogrič M, Žigon P, Lakota K, Praprotnik S, Drobne D, Štabuc B, Sodin-Semrl S, Čučnik S.

Clin Rheumatol. 2019 Feb;38(2):361-370. doi: 10.1007/s10067-018-4213-0. Epub 2018 Jul 16.

PMID:
30014359
10.

Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.

Kuret T, Lakota K, Mali P, Čučnik S, Praprotnik S, Tomšič M, Sodin-Semrl S.

PLoS One. 2018 Apr 4;13(4):e0195346. doi: 10.1371/journal.pone.0195346. eCollection 2018.

11.
12.

Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature.

Chen DY, Lau CS, Elzorkany B, Hsu PN, Praprotnik S, Vasilescu R, Marshall L, Llamado L.

Int J Rheum Dis. 2018 Feb;21(2):362-372. doi: 10.1111/1756-185X.13238. Epub 2017 Dec 4. Review.

PMID:
29205904
13.

A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods.

Burja B, Kuret T, Sodin-Semrl S, Lakota K, Rotar Ž, Ješe R, Mrak-Poljšak K, Žigon P, Thallinger GG, Feichtinger J, Čučnik S, Tomšič M, Praprotnik S, Hočevar A.

Autoimmun Rev. 2018 Feb;17(2):188-194. doi: 10.1016/j.autrev.2017.11.022. Epub 2017 Nov 28. Review.

PMID:
29196244
14.

NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis.

Jenko B, Praprotnik S, Tomšic M, Dolžan V.

J Med Biochem. 2016 Sep;35(3):319-323. doi: 10.1515/jomb-2016-0008. Epub 2016 Jul 6.

15.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, De Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X, Ramos-Casals M; EULAR-SS Task Force Big Data Consortium.

Ann Rheum Dis. 2017 Jun;76(6):1042-1050. doi: 10.1136/annrheumdis-2016-209952. Epub 2016 Nov 29.

PMID:
27899373
16.

Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits.

Ogrič M, Terčelj M, Praprotnik S, Tomšič M, Božič B, Sodin-Semrl S, Čučnik S.

Immunol Res. 2017 Feb;65(1):172-185. doi: 10.1007/s12026-016-8824-8. Review.

PMID:
27421721
17.

Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry.

Bizjak M, Bruck O, Praprotnik S, Dahan S, Shoenfeld Y.

Immunol Res. 2017 Feb;65(1):164-167. doi: 10.1007/s12026-016-8823-9.

PMID:
27421720
18.

Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine.

Bizjak M, Bruck O, Kanduc D, Praprotnik S, Shoenfeld Y.

Semin Hematol. 2016 Apr;53 Suppl 1:S48-50. doi: 10.1053/j.seminhematol.2016.04.014. Epub 2016 Apr 7.

PMID:
27312165
19.

Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.

Jenko B, Lusa L, Tomsic M, Praprotnik S, Dolzan V.

Pharmacogenomics J. 2017 Oct;17(5):412-418. doi: 10.1038/tpj.2016.36. Epub 2016 May 24.

PMID:
27217051
20.

Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.

Perdan-Pirkmajer K, Pirkmajer S, Thevis M, Thomas A, Praprotnik S, Hočevar A, Rotar Ž, Gašperšič N, Sodin-Šemrl S, Žibert J, Omersel J, Chibalin AV, Tomšič M, Ambrožič A.

Scand J Rheumatol. 2016 Oct;45(5):347-55. doi: 10.3109/03009742.2015.1105290. Epub 2016 Jan 4.

PMID:
26726793
21.

Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients.

Jenko B, Praprotnik S, Čučnik S, Rotar Ž, Tomšič M, Dolžan V.

Pharmacogenomics. 2016;17(1):45-9. doi: 10.2217/pgs.15.147. Epub 2015 Dec 14.

PMID:
26651826
22.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

23.

Comment on: High-risk pregnancy and the rheumatologist.

Praprotnik S, Rotar Z, Tomšič M.

Rheumatology (Oxford). 2015 Dec;54(12):2292. doi: 10.1093/rheumatology/kev369. Epub 2015 Oct 10. No abstract available.

PMID:
26454693
24.

Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry.

Rotar Z, Hočevar A, Rebolj Kodre A, Praprotnik S, Tomšič M; Slovenian Rheumatologists.

Clin Rheumatol. 2015 Oct;34(10):1787-93. doi: 10.1007/s10067-015-3066-z. Epub 2015 Sep 7.

PMID:
26345633
25.

Silicone implants and lymphoma: The role of inflammation.

Bizjak M, Selmi C, Praprotnik S, Bruck O, Perricone C, Ehrenfeld M, Shoenfeld Y.

J Autoimmun. 2015 Dec;65:64-73. doi: 10.1016/j.jaut.2015.08.009. Epub 2015 Aug 29. Review.

PMID:
26330346
26.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
27.

Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

Agmon-Levin N, Rosário C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, Stojanovich L, Blank M, Pierangeli S, Praprotnik S, Meis Ed, Seguro LP, Ruffatti A, Pengo V, Tincani A, Doria A, Shoenfeld Y.

Lupus. 2013 Nov;22(13):1327-35. doi: 10.1177/0961203313504633. Epub 2013 Sep 13.

PMID:
24036580
28.

Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.

Sieper J, Srinivasan S, Zamani O, Mielants H, Choquette D, Pavelka K, Loft AG, Géher P, Danda D, Reitblat T, Cantini F, Ancuta C, Erdes S, Raffayová H, Keat A, Gaston JS, Praprotnik S, Vastesaeger N.

Ann Rheum Dis. 2013 Oct;72(10):1621-7. doi: 10.1136/annrheumdis-2012-201777. Epub 2012 Oct 13.

PMID:
23065731
29.

Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

Perdan-Pirkmajer K, Thallinger GG, Snoj N, Čučnik S, Žigon P, Kveder T, Logar D, Praprotnik S, Tomšič M, Sodin-Semrl S, Ambrožič A.

Lupus. 2012 Feb;21(2):175-83. doi: 10.1177/0961203311429817.

PMID:
22235050
30.

International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.

Lakota K, Thallinger GG, Sodin-Semrl S, Rozman B, Ambrozic A, Tomsic M, Praprotnik S, Cucnik S, Mrak-Poljsak K, Ceribelli A, Cavazzana I, Franceschini F, Vencovsky J, Czirják L, Varjú C, Steiner G, Aringer M, Stamenkovic B, Distler O, Matucci-Cerinic M, Kveder T.

Arthritis Res Ther. 2012 Jan 6;14(1):R2. doi: 10.1186/ar3550.

31.
32.

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries.

Orlewska E, Ancuta I, Anic B, Codrenau C, Damjanov N, Djukic P, Ionescu R, Marinchev L, Nasonov EL, Peets T, Praprotnik S, Rashkov R, Skoupa J, Tlustochowicz W, Tlustochowicz M, Tomsic M, Veldi T, Vojinovic J, Wiland P.

Med Sci Monit. 2011 Apr;17(4):SR1-13.

33.

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.

Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22.

PMID:
21345815
34.

A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.

Perdan-Pirkmajer K, Praprotnik S, Tomšič M.

Clin Rheumatol. 2010 Dec;29(12):1465-7. doi: 10.1007/s10067-010-1553-9. Epub 2010 Aug 24. Review.

PMID:
20734215
35.

Prolactin's role in the pathogenesis of the antiphospholipid syndrome.

Praprotnik S, Agmon-Levin N, Porat-Katz BS, Blank M, Meroni PL, Cervera R, Miesbach W, Stojanovich L, Szyper-Kravitz M, Rozman B, Tomsic M, Shoenfeld Y.

Lupus. 2010 Nov;19(13):1515-9. doi: 10.1177/0961203310373781. Epub 2010 Jul 20.

PMID:
20647249
36.

Digital ulcers as the first manifestation of carpal tunnel syndrome.

Perdan-Pirkmajer K, Praprotnik S, Tomšič M.

Rheumatol Int. 2011 May;31(5):685-6. doi: 10.1007/s00296-009-1229-4. Epub 2009 Oct 24.

PMID:
19855970
37.

Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis.

Grabar PB, Rozman B, Logar D, Praprotnik S, Dolzan V.

Ann Rheum Dis. 2009 Aug;68(8):1367-8. doi: 10.1136/ard.2008.099093. No abstract available.

PMID:
19605743
38.

Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Praprotnik S, Ferluga D, Vizjak A, Hvala A, Avcin T, Rozman B.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):109-25. doi: 10.1007/s12016-008-8104-z. Review.

PMID:
19067253
39.

Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?

Gaspersic N, Sersa I, Jevtic V, Tomsic M, Praprotnik S.

Ann Rheum Dis. 2008 Sep;67(9):1354. doi: 10.1136/ard.2007.082537. No abstract available.

PMID:
18697784
40.

The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients.

Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y.

J Autoimmun. 2008 Feb-Mar;30(1-2):37-41. Epub 2007 Dec 26.

PMID:
18158235
41.

Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al.

Praprotnik S, Tomsic M.

Arthritis Rheum. 2007 Dec;56(12):4228; author reply 4228-9. No abstract available.

42.

Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Gaspersic N, Sersa I, Jevtic V, Tomsic M, Praprotnik S.

Skeletal Radiol. 2008 Feb;37(2):123-31. Epub 2007 Nov 22.

PMID:
18034343
43.

Leflunomide-associated tuberculosis?

Hocevar A, Rozman B, Praprotnik S, Lestan B, Erzen D, Petric V, Tomsic M.

Rheumatology (Oxford). 2006 Feb;45(2):228-9. Epub 2005 Nov 30. No abstract available.

PMID:
16319103
44.

Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosus.

Praprotnik S, Hocevar A, Ferlan-Marolt V, Tomsic M.

Lupus. 2005;14(6):493-4. No abstract available.

PMID:
16038116
45.

New issues in tuberculosis.

Praprotnik S, Rozman B, Tomsic M.

Ann Rheum Dis. 2005 May;64(5):795; author reply 795. No abstract available.

46.

Concerns about the prevalence of primary Sjögren's syndrome: comment on the article by Theander et al.

Rotar Z, Praprotnik S, Tomsic M.

Arthritis Rheum. 2005 Jan;52(1):369; author reply 369-70. No abstract available.

47.

Features associated with epilepsy in the antiphospholipid syndrome.

Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, van-Breda-Vriezman PJ, Damoiseaux J.

J Rheumatol. 2004 Jul;31(7):1344-8.

PMID:
15229954
48.

Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome.

Shoenfeld Y, Krause I, Kvapil F, Sulkes J, Lev S, von Landenberg P, Font J, Zaech J, Cervera R, Piette JC, Boffa MC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Vriezman VB, Blank M.

J Clin Immunol. 2003 Sep;23(5):377-83.

PMID:
14601646
49.

Parasympathetic nervous system dysfunction in primary Sjögren's syndrome.

Hocevar A, Tomsic M, Praprotnik S, Hojnik M, Kveder T, Rozman B.

Ann Rheum Dis. 2003 Aug;62(8):702-4. Review.

50.

Leflunomide and hypertension.

Rozman B, Praprotnik S, Logar D, Tomsic M, Hojnik M, Kos-Golja M, Accetto R, Dolenc P.

Ann Rheum Dis. 2002 Jun;61(6):567-9. No abstract available.

Supplemental Content

Loading ...
Support Center